Quadrivalent Vaccines Is A Crucial Strategy In Combating The Dual Burden Of Chronic And Infectious Diseases Emerges as a Core Driver of the Quadrivalent Market in 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Expected CAGR for the Quadrivalent Market Through 2025?
The market size of the quadrivalent has exhibited vigorous growth in the past few years. It is projected to increase from $8.87 billion in 2024 to $9.61 billion in 2025, showing a compound annual growth rate (CAGR) of 8.2%. Factors such as the complexity of the disease, educational programs, previous health incidences, advancements in technology, and the development of healthcare have contributed to this growth in the historic period.

What's the Projected Size of the Global Quadrivalent Market by 2029?
The market size of the quadrivalent is forecasted to experience a significant increase in the coming years, with a projected value of $14.22 billion by 2029. This growth, calculated at a compound annual growth rate (CAGR) of 10.3%, is influenced by global health incidents, competitive activity, educational initiatives, amendments in regulations, and changing patterns of diseases. Key trends over the forecast period are disease prevalence, regulatory climate, development in healthcare infrastructure, consumer knowledge and education, and competitive dynamics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Top Growth Drivers in the Quadrivalent Industry: What's Accelerating the Market?
The escalating frequency of persistent and transmissible illnesses is anticipated to bolster the expansion of the quadrivalent market. Persistent diseases are long-term illnesses resulting from genetics and lifestyle, while transmissible diseases arise from exposure to infectious organisms like viruses, bacteria, fungi, or protozoa. Quadrivalent vaccines play a crucial role in mitigating illness and death from serious infections, along with other diseases, apart from the specific ones they are structured to combat. They are employed to stave off chronic (non-communicable) diseases where infectious organisms partake in the genesis of cancer. For example, in September 2024, as stated in a report by the Centers for Disease Control and Prevention, a US-based non-profit organization, during Week 37, 0.5% of samples tested positive for influenza, with 91.4% being influenza A and 8.6% influenza B. However, cumulatively, from October 1, 2023 (Week 40), 8.7% of the samples were positive, out of which 69.2% were influenza A and 30.8% were influenza B. This shows an increased overall positivity rate and a substantial rise in influenza B cases over time. Hence, the escalating frequency of persistent and transmissible illnesses is promoting the expansion of the quadrivalent market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9335&type=smp

What Trends Will Shape the Quadrivalent Market Through 2029 and Beyond?
The introduction of novel products is a prevailing trend in the quadrivalent sector that is gaining traction. Most of the prominent players in the quadrivalent market are aiming to provide inventive solutions to reinforce their market standing. For example, AstraZeneca, a pharmaceutical corporation based in the UK, launched FluMist quadrivalent (Influenza Vaccination Live, Intranasal) in September 2022. It's an FDA-approved, needle-free, nasal-spray flu vaccine suitable for individuals aged 2 to 49. This live attenuated influenza vaccine (LAIV) is offered in either trivalent or quadrivalent formulas, and is covered by the majority of health insurance plans in addition to the children's vaccine scheme.

What Are the Main Segments in the Quadrivalent Market?
The quadrivalent market covered in this report is segmented -

1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray
2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies
3) By Disease: Cancer, Hepatitis, Pneumococcal Disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)

Subsegments:
1) By Intradermal Shot: Standard Intradermal Injection, Needle-Free Intradermal Delivery
2) By Intramuscular Injection: Standard Intramuscular Injection, Adjuvanted Intramuscular Injection
3) By Nasal Spray: Live Attenuated Nasal Spray, Inactivated Nasal Spray

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9335&type=smp

Which Top Companies are Driving Growth in the Quadrivalent Market?
Major companies operating in the quadrivalent market include AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Emergent BioSolutions Inc., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)

Which Regions Will Dominate the Quadrivalent Market Through 2029?
North America was the largest region in the quadrivalent market in 2024. The regions covered in the quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9335

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.